Expensive drugs to be cut from cancer drugs fund

By Sarah Calkin2014-11-11T10:39:00

NHS England is to start evaluating the cost effectiveness of medicines available through the cancer drugs fund in a bid to bring the budget under control

You need to be signed in to read more

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

All of HSJ.co.uk and our HSJ mobile app
News and insight on all areas of public funded healthcare
Expert commentary, insight and analysis from industry leaders
9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

to HSJ

Sign into your account here